D-Minus Hemolytic Uremic Syndrome
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About D-Minus Hemolytic Uremic Syndrome

What is the definition of D-Minus Hemolytic Uremic Syndrome?
D-minus (diarrhea negative) hemolytic uremic syndrome is an extremely rare, progressive genetic disease characterized by low levels of red blood cells (hemolytic anemia), low platelets (thrombocytopenia), and an inability of the kidneys to process waste products from the blood (uremia).
What are the symptoms of D-Minus Hemolytic Uremic Syndrome?
Symptoms of D-minus hemolytic uremic syndrome may include malaise, fatigue, irritability, lethargy, decreased urine, paleness, scattered bruising, gastrointestinal bleeding, high blood pressure, headaches, double vision, facial paralysis, stroke, seizures, coma, fluid in the lungs, enlarged heart, and kidney failure.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for D-Minus Hemolytic Uremic Syndrome?
Treatment for D-minus hemolytic uremic syndrome may include intravenous nutrition and fluid replacement, kidney or peritoneal dialysis, blood transfusion, vasodilators, medications, such as eculizumab and ultomiris (favulizumab-cwyz), plasma exchange (plasmapheresis), immunosuppressive therapy, or kidney transplant.
Who are the top D-Minus Hemolytic Uremic Syndrome Local Doctors?
Elite in D-Minus Hemolytic Uremic Syndrome
Pathology | Hematology | Oncology
Elite in D-Minus Hemolytic Uremic Syndrome
Pathology | Hematology | Oncology
Referral may be required

Sidney Kimmel Comprehensive Cancer Center

401 North Broadway Street, Weinberg BLDG, Weinberg BLDG, 
Baltimore, MD 
Languages Spoken:
English

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Elite provider by MediFind in the treatment of D-Minus Hemolytic Uremic Syndrome. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine.

Advanced in D-Minus Hemolytic Uremic Syndrome
Hematology | Oncology
Advanced in D-Minus Hemolytic Uremic Syndrome
Hematology | Oncology
Referral may be required

Advocate Infusion Center

525 E Congress Pkwy, Ste 300, 
Crystal Lake, IL 
Languages Spoken:
English
Offers Telehealth

Thomas Weyburn is a Hematologist and an Oncologist practicing medicine in Crystal Lake, Illinois. Dr. Weyburn is rated as an Advanced provider by MediFind in the treatment of D-Minus Hemolytic Uremic Syndrome. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Familial Colorectal Cancer. Dr. Weyburn is board certified in American Board Of Internal Medicine, Hematology.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in D-Minus Hemolytic Uremic Syndrome
Elite in D-Minus Hemolytic Uremic Syndrome
Referral may be required
Milan, IT 

Gianluigi Ardissino practices practicing medicine in Milan, Italy. Mr. Ardissino is rated as an Elite expert by MediFind in the treatment of D-Minus Hemolytic Uremic Syndrome. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Hemolytic-Uremic Syndrome, D-Minus Hemolytic Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, Atypical Hemolytic Uremic Syndrome (aHUS), and Kidney Transplant.

What are the latest D-Minus Hemolytic Uremic Syndrome Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Hyperhydration to Improve Kidney Outcomes in Children With Shiga Toxin-Producing E. Coli Infection: A Multinational Embedded Cluster Crossover Randomized Trial

Summary: The objective of this study is to determine if early high volume intravenous fluid administration (hyperhydration) may be effective in mitigating or preventing complications of shiga toxin-producing E. coli (STEC) infection in children and adolescents when compared with traditional approaches (conservative fluid management).